Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sang Baek Ryu, Ph.D.

Concepts (78)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms3201613620.190 Why?
Phthalazines120203570.150 Why?
Ovarian Neoplasms5202048140.150 Why?
Genes, BRCA2120206170.140 Why?
Genes, BRCA1120207790.140 Why?
Lymph Nodes2201634650.130 Why?
Carcinoma, Endometrioid120162750.110 Why?
Germ-Line Mutation1202018010.100 Why?
Uterine Cervical Neoplasms3201520190.090 Why?
Water Movements12009170.090 Why?
Piperazines1202024740.090 Why?
Genital Neoplasms, Female120155140.090 Why?
Water Microbiology120091160.090 Why?
Neoplasms, Glandular and Epithelial120134880.080 Why?
Lymphatic Metastasis1201629080.080 Why?
Neoplasm Recurrence, Local4202091290.070 Why?
Camptothecin120085580.060 Why?
Ovary120099810.060 Why?
Antineoplastic Agents, Phytogenic120086210.060 Why?
Neoplasms, Germ Cell and Embryonal120094880.060 Why?
CA-125 Antigen220162740.060 Why?
Republic of Korea220165450.050 Why?
Pelvis220167020.050 Why?
Models, Statistical2201351140.050 Why?
Antineoplastic Combined Chemotherapy Protocols22020113950.050 Why?
Lymph Node Excision2201612430.050 Why?
Platinum Compounds12020970.040 Why?
Models, Biological2201296150.040 Why?
Gynecologic Surgical Procedures220133350.040 Why?
Preoperative Period120165480.030 Why?
Uterus120167130.030 Why?
Oligohymenophorea1200910.020 Why?
Principal Component Analysis120139410.020 Why?
Oceans and Seas12009500.020 Why?
Neoplasm Staging22016109680.020 Why?
Hysterectomy120169240.020 Why?
Middle Aged820202131150.020 Why?
Adult820202132830.020 Why?
Korea12009990.020 Why?
Aged, 80 and over32020577380.020 Why?
Topoisomerase I Inhibitors12008650.020 Why?
Female1020203785100.020 Why?
Finite Element Analysis120094300.020 Why?
Aged520201626790.020 Why?
Organoplatinum Compounds120084120.020 Why?
Antineoplastic Agents12009136380.020 Why?
Young Adult32016562390.010 Why?
Humans1020207369400.010 Why?
Prognosis22016289670.010 Why?
Cohort Studies22016402930.010 Why?
Sensitivity and Specificity12016147380.010 Why?
Risk1201397040.010 Why?
Chemotherapy, Adjuvant1200934570.010 Why?
Retrospective Studies32016762000.010 Why?
Drug Administration Schedule1200849350.010 Why?
Survival Analysis12012102610.010 Why?
Disease-Free Survival1200968920.010 Why?
Logistic Models12013134080.010 Why?
Models, Theoretical1200936020.010 Why?
Combined Modality Therapy1200986010.010 Why?
Enzyme Inhibitors1200838120.010 Why?
Membrane Proteins1201379040.010 Why?
Computer Simulation1200962060.010 Why?
Positron-Emission Tomography1201263270.010 Why?
Reproducibility of Results12013197770.010 Why?
Drug Resistance, Neoplasm1200851520.010 Why?
Prospective Studies12016528060.010 Why?
Risk Assessment12012232980.010 Why?
Tomography, X-Ray Computed12013200510.010 Why?
Magnetic Resonance Imaging12016352560.010 Why?
Algorithms12009138690.010 Why?
Risk Factors12016717840.010 Why?
Time Factors12009401310.000 Why?
Follow-Up Studies12009389370.000 Why?
Child, Preschool12009407850.000 Why?
Child12009767000.000 Why?
Adolescent12009852250.000 Why?
Animals120091687350.000 Why?
Ryu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.